Semin intervent Radiol 2022; 39(05): 533-536
DOI: 10.1055/s-0042-1757943
Morbidity & Mortality

Lymphorrhea following Tunneled Femoral Central Venous Catheter Placement: Avoidance and Management of a Rare Complication

Autoren

  • Daniel Rzewnicki

    1   Division of Interventional Radiology and Image-Guided Medicine, Department of Radiology and Imaging Sciences, Emory University Hospital, Atlanta, Georgia
  • Mohammed F. Loya

    1   Division of Interventional Radiology and Image-Guided Medicine, Department of Radiology and Imaging Sciences, Emory University Hospital, Atlanta, Georgia
  • Hearns Charles

    1   Division of Interventional Radiology and Image-Guided Medicine, Department of Radiology and Imaging Sciences, Emory University Hospital, Atlanta, Georgia
  • Nima Kokabi

    1   Division of Interventional Radiology and Image-Guided Medicine, Department of Radiology and Imaging Sciences, Emory University Hospital, Atlanta, Georgia
  • Nariman Nezami

    2   Division of Vascular and Interventional Radiology, Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, Maryland
  • Bill S. Majdalany

    3   Department of Radiology, University of Vermont Medical Center, Burlington, Vermont

Lymphatic injury and chylothorax are known, albeit rare, complications of both right and left internal jugular central venous catheter placement.[1] [2] Some reports suggest that these complications occur more frequently when lines are placed in the presence of other complicating factors such as infection or thrombosis.[3] [4] [5] [6] [7] [8] Although rare, the potential for a peripheral lymphatic injury is present during vascular access adjacent to the inguinal nodal cluster. A case of iatrogenic peripheral lymphatic injury during placement of a femoral tunneled central venous catheter (TCVC) is described. We review peripheral lymphatic anatomy, suggest approaches to avoid inadvertent lymphatic injury, and discuss management strategies of a peripheral lymphatic injury.

Authors' Contribution

All authors have read and contributed to this manuscript.


Disclosures

The authors have no relevant disclosures.


N.K.: Research Grant and Consultant—Sirtex Medical


N.N.: Scientific Advisory Board: Embolx and RenovoRx; Consultant: CAPS Medical


B.S.M.: Scientific Advisory Board—Balt Medical


There was no grant funding or financial support for this manuscript.




Publikationsverlauf

Artikel online veröffentlicht:
20. Dezember 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA